Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13-Reference-Cited by-同舟云学术

Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13

Published:2008-09-14 Issue:10 Volume:40 Page:1156-1159
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Barton Anne, ,Thomson Wendy,Ke Xiayi,Eyre Steve,Hinks Anne,Bowes John,Plant Darren,Gibbons Laura J,Wilson Anthony G,Bax Deborah E,Morgan Ann W,Emery Paul,Steer Sophia,Hocking Lynne,Reid David M,Wordsworth Paul,Harrison Pille,Worthington Jane, ,

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.218.pdf

Reference12 articles.

1. The Wellcome Trust Case Control Consortium. Nature 447, 661–678 (2007).

2. Thomson, W. et al. Nat. Genet. 39, 1431–1433 (2007).

3. Plenge, R.M. et al. Nat. Genet. 39, 1477–1482 (2007).

4. Huizinga, T.W. et al. Arthritis Rheum. 52, 3433–3438 (2005).

5. Hayashi, K. & Altman, A. Pharmacol. Res. 55, 537–544 (2007).

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network Pharmacology, Molecular Docking and in vivo-based Analysis on the Effects of the MBZM-N-IBT for Arthritis;Current Computer-Aided Drug Design;2024-08-06

2. The Regulation Networks of Chinese Medicines Against Rheumatoid Arthritis with Syndrome of Deficiency of Liver and Kidney;2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2022-12-06

3. The Chinese Medicines of Integrated Therapies Against Rheumatoid Arthritis Retard Osteoporosis;2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2022-12-06

4. The Chinese Medicines Reduce Osteoporosis Caused by Therapy of Glucocorticoids and Tafacitinib Against Rheumatoid Arthritis;2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2022-12-06

5. The complement system and human autoimmune diseases;Journal of Autoimmunity;2022-12